期刊文献+

65例多原发癌的临床回顾性研究 被引量:57

Retrospective investigation of 65 cases with multiple primary cancers
下载PDF
导出
摘要 目的探讨多原发癌(multiple primary cancers,MPC)的发病特点、早期诊断、治疗和预后,以期提高对多原发癌的诊治水平。方法对我院1998年1月至2008年12月收治的65例MPC患者的临床资料进行回顾性分析。结果研究期间,在10 834例恶性肿瘤患者中发现MPC 65例,MPC的总体发生率为0.6%(65/10 834)。其中,双重癌发生率为0.4%(46/10 834),三重癌发生率为0.1%(16/10 834),四重癌发生率为0.02%(3/10 834)。发病间隔时间在3年以内者有13例,在3~5年者有22例,最长间隔时间为35年。首发癌和重复癌均以消化系统肿瘤最常见,其次是乳腺癌、泌尿生殖系统肿瘤及头颈部肿瘤。所有患者经病理学检查均为恶性肿瘤,经外科手术或放、化疗后的3年生存率为65%,5年生存率为40%。结论加强对MPC发病规律的认识,做到早期诊断、积极治疗,可延长生存期、改善预后。 Objective To explore characteristics,early diagnosis,treatment and prognosis of multiple primary cancers(MPC) in order to promote its diagnosis and therapy. Methods Sixty-five MPC cases in our hospital from Jan.1998 to Dec.2008 were studied retrospectively. Results Sixty-five MPC cases were found in 10 834 cases with malignant tumors,and the incidence of MPC was 0.6%(65/10 834),in which the incidences of duplex primary cancers,triple primary cancers and quadruple primary cancers were 0.4%(46/10 834),0.1%(16/10 834) and 0.02%(3/10 834),respectively.Thirteen cases had the interval no more than 3 years between the first occurrence and the recurrence,and 22 cases had the interval of 3-5 years.The longest interval was 35 years.Primary cancer and repetitive cancer occurred most frequently in digestive system with the next in breast,genitourinary system and head and neck.The 3-year and 5-year survival rate were 65% and 40%,respectively. Conclusions The mechanism and development of MPC should be researched further.Early diagnosis and active treatment can prolong the survival span and improve prognosis of MPC patients.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2010年第5期591-593,共3页 Fudan University Journal of Medical Sciences
关键词 多原发癌 诊断 治疗 预后 multiple primary cancers diagnosis treatment prognosis
  • 相关文献

参考文献6

二级参考文献35

  • 1蒋嘉德.食管癌伴发其它脏器重复癌23例报告[J].肿瘤防治研究,1994,21(4):257-257. 被引量:4
  • 2李威,詹友庆,李国辉.双原发癌156例临床分析[J].中华肿瘤杂志,1996,18(4):296-298. 被引量:73
  • 3刘复生.多原发癌瘤172例临床病理分析[J].中华肿瘤杂志,1979,2:113-118. 被引量:58
  • 4沈志祥 陈志术.抗瘤治疗引起的第二肿瘤.肿瘤,1993,13(6):274-276. 被引量:7
  • 5Thomas GA. Solid cancers after therapeutic radiation : can we predict which patients are most at risk[ J] .9 Clin Oncol (R Coil Radiol), 2004,16 ( 6 ) :429-434. 被引量:1
  • 6Kay SF, Salehpour M, Followill DS, et al. The calculated risk of fatal secondary malignancies from intensity-modulated therapy [J]. Int J Radiat Oncol Biol Phys, 2005,62(3) :1195-1203. 被引量:1
  • 7Schneider U, Zwahlen D, Ross D, et al. Estimation of radiationinduced cancer from three-dimensional dose distributions;concept of organ equivalent dose [ J ]. Int J Radiat Oncol Biol Phys, 2005,62(5 ) : 1510-1515. 被引量:1
  • 8Verellen D, Vanhavere F. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region[J]. Radiother Oncol, 1999,53( 1 ) :199-203. 被引量:1
  • 9Hall E, Wuu CS. Rdiation-induced second cancers: The impact of 3D-CRT and IMRT[ J]. Int J Radiat Oncol Biol Phys, 2003, 56( 1 ) :83-88. 被引量:1
  • 10Wittekind C, Klimpfinger M, Hermanek P, et al. Multiple simultaneous gastric carcinomas [ J ]. Br J Cancer, 1997,76 ( 12 ) : 1604- 1609. 被引量:1

共引文献96

同被引文献298

引证文献57

二级引证文献165

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部